| 804608 |
PHARMACEUTICALS |
Influence of Semiquantitative [18F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis |
2022-02-14 |
10.3390/ph15020224 |
Cegla Paulina, Currie Geoffrey, Wróblewska Joanna P., Cholewiński Witold, Kaźmierska Joanna, Marszałek Andrzej, Kubiak Anna, Golusinski Pawel, Golusiński Wojciech, Majchrzak Ewa |
| 804607 |
CANCERS |
A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes |
2022-02-14 |
10.3390/cancers14040939 |
Woods Kaley E., Ma Ting Martin, Cook Kiri A., Morris Eric D., Gao Yu, Sheng Ke, Kishan Amar U., Hegde John V., Felix Carol, Basehart Vincent, Narahara Kelsey, Shen Zhouhuizi, Tenn Stephen, Steinberg Michael L., Chin Robert K., Cao Minsong |
| 804606 |
CANCERS |
Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy |
2022-02-14 |
10.3390/cancers14040943 |
Steur Anouk, Raymakers-Janssen Paulien A. M. A., Kneyber Martin C. J., Dijkstra Sandra, van Woensel Job B. M., van Waardenburg Dick A., van de Ven Cornelis P., van der Steeg Alida F. W., Wijnen Marc, Lilien Marc R., de Krijger Ronald R., van Tinteren Harm, Littooij Annemieke S., Janssens Geert O., Peek Annemarie M. L., Tytgat Godelieve A. M., Mavinkurve-Groothuis Annelies M., van Grotel Martine, van den Heuvel-Eibrink Marry M., Asperen Roelie M. Wösten-van |
| 804605 |
CANCERS |
Impact of Open Dialogue about Complementary Alternative Medicine—A Phase II Randomized Controlled Trial |
2022-02-14 |
10.3390/cancers14040952 |
Stie Mette, Delmar Charlotte, Nørgaard Birgitte, Jensen Lars Henrik |
| 804604 |
CANCERS |
Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges |
2022-02-14 |
10.3390/cancers14040947 |
Rafii Saeed, Tashkandi Emad, Bukhari Nedal, Al-Shamsi Humaid O. |
| 804603 |
CANCERS |
Minimally Invasive Endoscopic and Surgical Management of Rectal Neoplasia |
2022-02-14 |
10.3390/cancers14040948 |
Al Ghamdi Sarah S., Leeds Ira, Fang Sandy, Ngamruengphong Saowanee |
| 804602 |
CANCERS |
Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERa-Positive Breast Cancer |
2022-02-14 |
10.3390/cancers14040954 |
Vafeiadou Vasiliki, Hany Dina, Picard Didier |
| 804601 |
CANCERS |
Tumor Accumulation of PIP-Based KRAS Inhibitor KR12 Evaluated by the Use of a Simple, Versatile Chicken Egg Tumor Model |
2022-02-14 |
10.3390/cancers14040951 |
Higashi Yuya, Ikeda Shuji, Matsumoto Kotaro, Satoh Shinsuke, Komatsu Aoi, Sugiyama Hiroshi, Tamanoi Fuyuhiko |
| 804600 |
CANCERS |
Quantitative Analysis of Radiation-Associated Parenchymal Lung Change |
2022-02-14 |
10.3390/cancers14040946 |
Chandy Edward, Szmul Adam, Stavropoulou Alkisti, Jacob Joseph, Veiga Catarina, Landau David, Wilson James, Gulliford Sarah, Fenwick John D., Hawkins Maria A., Hiley Crispin, McClelland Jamie R. |
| 804599 |
CANCERS |
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer |
2022-02-14 |
10.3390/cancers14040941 |
Forsare Carina, Vistrand Sara, Ehinger Anna, Lövgren Kristina, Rydén Lisa, Fernö Mårten, Narbe Ulrik |
